Slow-release oral morphine versus methadone: A crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence

Addiction

Volumn 99, Issue 8, 2004, Pages 940-945

  Mitchell, Timothy B ^a,d   White, Jason M ^a,b   Somogyi, Andrew A ^a,c   Bochner, Felix ^a,c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Drug & Alcohol Services South Australia   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Methadone; Opiate dependence; Sustained release morphine; Treatment outcomes

Indexed keywords

BUPRENORPHINE; LEVACETYLMETHADOL; METHADONE; MORPHINE; MORPHINE SULFATE; MU OPIATE RECEPTOR AGONIST; NARCOTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEMOGRAPHY; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; DRUG USE; DRUG WITHDRAWAL; HUMAN; MAINTENANCE THERAPY; MALE; OPEN STUDY; OPIATE ADDICTION; OUTPATIENT; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLEEP; SLOW RELEASE FORMULATION; SOCIAL INTERACTION; TREATMENT OUTCOME; WEIGHT REDUCTION; WITHDRAWAL SYNDROME; COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; FEMALE; MIDDLE AGED; PATIENT SATISFACTION;

ADULT; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MALE; METHADONE; MIDDLE AGED; MORPHINE; NARCOTICS; OPIOID-RELATED DISORDERS; PATIENT SATISFACTION; TREATMENT OUTCOME;

EID: 7444244891     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2004.00764.x     Document Type: Article

References (22)

1. Ward, J., Mattick, R. P. & Hall, W. (1994) The effectiveness of methadone maintenance treatment: an overview. Drug and Alcohol Review. 13, 327-336.
2. Rosenblum, A., Magura, S. & Joseph, H. (1991) Ambivalence toward methadone treatment among intravenous drug users. Journal of Psychoactive Drugs, 23, 21-27.
3. Stancliff, S., Myers, J. E., Steinet, S. & Drucker, E. (2002) Beliefs about methadone in an inner-city methadone clinic. Journal of Urban Health. 79, 571-578.
4. Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L. & Bigelow, G. E. (2000) A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence, The New England Journal of Medicine, 343, 1290-1297.
5. Walsh, S. L., June, H. L., Schuh, K. J., Preston, K. L., Bigelow, G. E. & Stitzer, M. L. (1995) Effects of buprenorphine and methadone in methadone-maintained subjects. Psychopharmacology, 119, 268-276.
6. Kreek, M. J. & Vocci, F. J. (2002) History and current status of opioid maintenance treatments: blending conference session. Journal of Substance Abuse Treatment, 23, 93-105.
7. Gourlay, G. K., Cherry, D. A., Onley, M. M., Tordoff, S. G., Conn, D. A., Hood, G. M. & Plummer, J. L. (1997) Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain. Pain, 69, 295-302.
8. Gourlay, G. K. (1998) Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine. Clinical Pharmacokinetics, 35, 173-190.
9. Fischer, G., Presslich, O., Diamant K., Schneider, C., Pezawas, L. & Kasper, S. (1996) Oral morphine-sulphate in the treatment of opiate dependent patients. Alcoholism, 32, 35-43.
10. Mitchell, T. B., White, J. M., Somogyi, A. A. & Bochner, F. (2003) Comparative pharmacodynamics and pharmacokinetics of methadone and slow-release oral morphine for maintenance treatment of opioid dependence. Drug and Alcohol Dependence, 72, 85-94.
11. Kraigher, D., Ortner, R., Eder, H., Schindler, S. & Fischer, G. (2002) Slow release of morphine hydrochloride for maintenance therapy of opioid dependence. Wiener Klinische Wochenschrift, 114, 904-910.
12. Brewer, C. (1995) Recent developments in maintenance prescribing and monitoring in the United Kingdom. Bulletin of the New York Academy of Medicine, 72, 359-370.
13. Sherman, J. P. (1996) Managing heroin addiction with a long-acting morphine product (Kapanol). The Medical Journal of Australia, 165, 239.
14. Dyer, K. R. & White, J. M. (1997) Patterns of symptom complaints in methadone maintenance patients. Addiction, 92, 1445-1455.
15. White, J. M., Danz, C., Kneebone, J., La Vincente, S. F., Newcombe, D. A. & Ali, R. L. (2002) Relationship between LAAM-methadone preference and treatment outcomes. Drug and Alcohol Dependence, 66, 295-301.
16. Ware, J. E., Snow, K. K., Kosisnki, M. & Gandek, B. (1993) SF-36 Health Survey Manual and Interpretation Guide. Boston: The Health Institute.
17. Beck, A. T., Steer, R. A. & Brown, G. K. (1996) The Beck Depression Inventory Manual. San Antonio: The Psychological Corporation.
18. Parrott, A. C. & Hindmarch, I. (1980) The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations - a review. Psychopharmacology, 71, 173-179.
19. Mercadante, S., Casuccio, A. & Calderone, L. (1999) Rapid switching from morphine to methadone in cancer patients with poor response to morphine. Journal of Clinical Oncology, 17, 3307-3312.
20. Ripamonti, C., De Conno, F., Groff, L., Belzile, M., Pereira, J., Hanson, J. & Bruera, E. (1998) Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences. Annals of Oncology, 9, 79-83.
21. Ripamonti, C., Groff, L., Brunelli, C., Polastri, D., Stavrakis, A. & De Conno, F. (1998) Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? Journal of Clinical Oncology, 16, 3216-3221.
22. Bruera, E. & Fainsinger, R. L. (1997) Pharmacologic treatment of cancer pain. The New England Journal of Medicine, 336, 962-963.